Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Avanos Medical (AVNS) EBT (2016 - 2025)

Avanos Medical's EBT history spans 11 years, with the latest figure at $9.5 million for Q3 2024.

  • For Q3 2024, EBT rose 465.38% year-over-year to $9.5 million; the TTM value through Sep 2024 reached $26.1 million, up 1144.0%, while the annual FY2023 figure was -$7.9 million, 129.59% down from the prior year.
  • EBT for Q3 2024 was $9.5 million at Avanos Medical, up from $6.2 million in the prior quarter.
  • Across five years, EBT topped out at $16.5 million in Q2 2022 and bottomed at -$49.8 million in Q4 2020.
  • The 5-year median for EBT is -$2.6 million (2023), against an average of -$2.5 million.
  • The largest annual shift saw EBT crashed 666.15% in 2020 before it surged 465.38% in 2024.
  • A 5-year view of EBT shows it stood at -$49.8 million in 2020, then surged by 53.61% to -$23.1 million in 2021, then soared by 161.9% to $14.3 million in 2022, then tumbled by 37.76% to $8.9 million in 2023, then increased by 6.74% to $9.5 million in 2024.
  • Per Business Quant, the three most recent readings for AVNS's EBT are $9.5 million (Q3 2024), $6.2 million (Q2 2024), and $1.5 million (Q1 2024).